Q4 2025 · 13F-HR
Avidity Partners Management LPholdings as filed
Filed 2026-02-13 · accession 0001791827-26-000002
$346.7M
Reported value
39
Positions
2025-12-31
Period end
The Brief · Avidity Partners Management LP · Q4 2025
AI · grounded in 13F
Avidity Partners Management LP closed its position in BMY, reducing exposure by $11.6M. The fund established new positions in ALNY for $8.35M, ICLR for $6.03M, and A for $5.65M. Additionally, the manager trimmed its holdings in NTRA by 83.2% and DHR by 68.9%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $86.7M | 25.0% | 2,104,184 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $61.1M | 17.6% | 1,472,699 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $21.6M | 6.23% | 1,400,708 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $20.0M | 5.77% | 660,424 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $13.0M | 3.76% | 417,300 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $10.9M | 3.15% | 114,500 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $10.3M | 2.98% | 107,600 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $8.8M | 2.55% | 3,210,733 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $8.4M | 2.41% | 21,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $8.2M | 2.38% | 50,300 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $8.1M | 2.33% | 5,504,855 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $7.8M | 2.25% | 9,520 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $6.0M | 1.74% | 33,100 | Common | SOLE |
| 00846U101 | A | AGILENT TECHNOLOGIES INC | $5.6M | 1.63% | 41,500 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $5.1M | 1.46% | 203,600 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $4.9M | 1.42% | 119,400 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $4.0M | 1.16% | 232,800 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $3.9M | 1.12% | 17,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $3.9M | 1.12% | 6,700 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $3.4M | 0.99% | 67,300 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $3.4M | 0.99% | 206,076 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $3.4M | 0.97% | 31,600 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $3.2M | 0.92% | 11,600 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $3.2M | 0.92% | 9,400 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.1M | 0.89% | 17,700 | Common | SOLE |
| 941848103 | WAT | WATERS CORP | $3.1M | 0.89% | 8,100 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $2.9M | 0.82% | 106,900 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $2.8M | 0.82% | 92,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $2.7M | 0.78% | 11,800 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $2.5M | 0.72% | 4,699,411 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $2.4M | 0.69% | 169,000 | Common | SOLE |
| 45826H109 | ITGR | INTEGER HLDGS CORP | $2.3M | 0.67% | 29,800 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $2.2M | 0.62% | 140,300 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $2.0M | 0.58% | 19,300 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $1.5M | 0.45% | 16,900 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $1.3M | 0.38% | 2,081,660 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $991,804 | 0.29% | 4,400 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $990,406 | 0.29% | 134,566 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $765,600 | 0.22% | 22,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.